Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder


Department of Health and Social Care written question – answered on 9th February 2018.

Alert me about debates like this

Photo of Lord Hunt of Kings Heath Lord Hunt of Kings Heath Shadow Spokesperson (Cabinet Office), Shadow Spokesperson (Education), Shadow Spokesperson (Health and Social Care)

To ask Her Majesty's Government whether they have evidence showing that there are more cost-effective products available than liothyronine for the treatment of thyroid disease; and if so, whether they will publish that evidence.

Photo of Lord O'Shaughnessy Lord O'Shaughnessy The Parliamentary Under-Secretary for Health and Social Care

NHS England have sought advice from the leading clinical experts in this field. These are the Royal College of Physicians, the British Thyroid Association and the European Thyroid Association. These experts recommend that, for the vast majority of patients, levothyroxine alone is used in the treatment of hypothyroidism. They also advise that liothyronine should be considered in exceptional circumstances.

Does this answer the above question?

Yes0 people think so

No4 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.